2024-04-24 10:23:46 ET
More on United Therapeutics
- United Therapeutics: Neutral Stance On Tyvaso's Patent Challenges And Future Growth Prospects
- United Therapeutics Corporation (UTHR) Q4 2023 Earnings Call Transcript
- United Therapeutics Corporation 2023 Q4 - Results - Earnings Call Presentation
- United Therapeutics motion for restraining order over Liquidia's Yutrepia denied
- Liquidia gains after court win in patent dispute with United Therapeutics
Read the full article on Seeking Alpha
For further details see:
Doctors perform first combined heart pump and pig kidney transplant surgery